Top

BMC Complementary Medicine and Therapies

Published in:

Open Access 01-12-2020 | Research article

Emodin protected against retinal ischemia insulted neurons through the downregulation of protein overexpression of β-catenin and vascular endothelium factor

Authors: Howard Wen-Haur Chao, Yu-Kuang Chen, Jorn-Hon Liu, Hwai-Tzong Pan, Hsin-May Lin, Hsiao-Ming Chao

Published in: BMC Complementary Medicine and Therapies | Issue 1/2020

Abstract

Background

Emodin has been proved to have an anti-ischemic effect on the brain, however little research has been done on its effect on vision-threatening retinal ischemia. Thus, an investigation was carried out into the hypothetical efficacy of emodin against retinal ischemia and the role of β-catenin/VEGF in its therapeutic mechanism.

Methods

Retinal ischemia, followed by reperfusion (IR), was inducted by raising the intraocular pressure of a Wistar rat’s eye to 120 mmHg for 60 min. Additionally, pre-ischemic/post-ischemic intravitreous injections of emodin (4, 10 and 20 μM) or vehicle were carried out on the eye with retinal ischemia. MTT assay, electroretinograms, cresyl violet staining retinal thickness measurements, and fluorogold retrograde labelling of retinal ganglion cells (RGCs) as well as Western blotting were carried out.

Results

Cultured RGC-5 cells subjected to oxygen glucose deprivation (OGD) were used to confirm the effective concentrations of emodin (administered 1 h pre-OGD, pre-OGD emodin). The most effective and significant (P = 0.04) dose of pre-OGD emodin was observed at 0.5 μM (cell viability: 47.52 ± 3.99%) as compared to pre-OGD vehicle treatment group (38.30 ± 2.51%). Furthermore, pre-ischemic intravitreous injection of 20 μM emodin (Emo20 + IR = 0.99 ± 0.18, P < 0.001) significantly attenuated the ischemia induced reduction in ERG b-wave amplitude, as compared to pre-ischemic intravitreous vehicle (Vehicle+IR = 0.04 ± 0.02). Post-ischemic intravitreous 20 μM emodin also significantly (P < 0.001) attenuated the ischemia associated b-wave reduction (IR + Em20 = 0.24 ± 0.09). Compared with pre-ischemic intravitreous vehicle (Vehicle+IR; whole retina thickness = 71.80 ± 1.08 μm; inner retina thickness = 20.97 ± 0.85 μm; RGC =2069.12 ± 212.82/0.17mm²), the significant (P < 0.001) protective effect was also present with pre-ischemic administration of emodin. This was shown by observing cresyl violet stained retinal thickness (Emo20 + IR: whole retina = 170.10 ± 0.10 μm; inner retina = 70.65 ± 2.06 μm) and retrograde fluorogold immunolabeled RGC density (4623.53 ± 179.48/0.17mm²). As compared to the normal control (the ratio of β-catenin/VEGF to β-actin was set as 1 in the Sham group), the β-catenin/VEGF protein level significantly (P < 0.001) increased after retinal ischemia and when pre-ischemic intravitreous vehicle (Vehicle+IR = 1.64 ± 0.14/7.67 ± 2.57) was carried out. However, these elevations were significantly (P = 0.02) attenuated by treatment with emodin 20 μM (Emo20 + IR = 1.00 ± 0.19/1.23 ± 0.44).

Conclusions

The present results suggest that emodin might protect against retinal ischemia insulted neurons such as RGCs by significantly downregulating the upregulation of β-catenin/VEGF protein that occurs during ischemia.

Available only for authorised users

Chao HM, Hu L, Cheng JM, Liu XQ, Liu JH, Pan WH, et al. Chi-Ju-Di-Huang-wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase. Chin Med. 2016;11(1):39. https://doi.org/10.1186/s13020-016-0109-6.CrossRef

Buchi ER, Suivaizdis I, Fu J. Pressure-induced retinal ischemia in rats: an experimental model for quantitative study. Ophthalmologica. 1991;203(3):138–47. https://doi.org/10.1159/000310240.CrossRef

Peng PH, Chao HM, Juan SH, Chen CF, Liu JH, Ko ML. Pharmacological preconditioning by low dose cobalt protoporphyrin induces heme oxygenase-1 overexpression and alleviates retinal ischemia-reperfusion injury in rats. Cur Eye Res. 2011;36:238–46. https://doi.org/10.3109/02713683.2010.539760.CrossRef

Li X, Xiang Y, Li F, Yin C, Li B, Ke X. WNT/β-catenin signaling pathway regulating T cell-inflammation in the tumor microenvironment. Front Immunol. 2019;10. https://doi.org/10.3389/fimmu.2019.02293.

Bok S, Kim Y, Woo Y, Kim S, Kang S, Lee Y, et al. Hypoxia-inducible factor-1α regulates microglial functions affecting neuronal survival in the acute phase of ischemic stroke in mice. Oncotarget. 2017;8(67):111508–21. https://doi.org/10.18632/oncotarget.22851.CrossRefPubMedPubMedCentral

Kaidi A, Williams AC, Paraskeva C. Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol. 2007;9(2):210–7. https://doi.org/10.1038/ncb1534.CrossRef

Zhou KK, Benyajati S, Le Y, Cheng R, Zhang W, Ma J. Interruption of Wnt signaling in Müller cells ameliorates ischemia-induced retinal neovascularization. PLoS One. 2014;9(10):e108454. https://doi.org/10.1371/journal.pone.0108454.CrossRef

Cao YJ, Pu ZJ, Tang YP, Shen J, Chen YY, Kang A, et al. Advances in bio-active constituents, pharmacology and clinical applications of rhubarb. Chin Med. 2017;12(1). https://doi.org/10.1186/s13020-017-0158-5.

Wang C, Zhang D, Ma H, Liu J. Neuroprotective effects of emodin-8-O-β-d-glucoside in vivo and in vitro. Eur J Pharmacol. 2007;577(1-3):58–63. https://doi.org/10.1016/j.ejphar.2007.08.033.CrossRef

10.

Vargas F, Díaz Y, Carbonell K. Antioxidant and Scavenging Activity of Emodin, Aloe-Emodin, and Rhein on Free-Radical and Reactive Oxygen Species. Pharmaceut Biol. 2004;42(4–5):342–8. https://doi.org/10.1080/13880200490519613.CrossRef

11.

Bonne C, Muller A, Villain M. Free radicals in retinal ischemia. Gen Pharmacol. 1998;30(3):275–80. https://doi.org/10.1016/S0306-3623(97)00357-1.CrossRef

12.

Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retinal Eye Res. 2004;23(1):91–147. https://doi.org/10.1016/j.preteyeres.2003.12.001.CrossRef

13.

Pellegrini-Giampietro D, Cherici G, Alesiani M, Carla V, Moroni F. Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J Neurosci. 1990;10(3):1035–41. https://doi.org/10.1523/JNEUROSCI.10-03-01035.1990.CrossRef

14.

Liu JL, Wang CX, Ning Y, Qi S, Zhang JS. The effects of emodin on the retinal ganglion cells in rats after ischemia reperfusion injury in rats. J China Med Univ. 2013;42(1):4–7. https://doi.org/10.3969/j.issn.0258-4646.2013.01.002.CrossRef

15.

Min YK, Park JH, Chong SA, Kim YS, Ahn YS, Seo JT, et al. Pyrrolidine dithiocarbamate-induced neuronal cell death is mediated by Akt, casein kinase 2, c-Jun N-terminal kinase, and IkB kinase in embryonic hippocampal progenitor cells. J Neurosci Res. 2003;71:689–700. https://doi.org/10.1002/jnr.10520.CrossRef

16.

Roy S, Nasser S, Yee M, Graves DT, Roy S. A long-term siRNA strategy regulates fibronectin overexpression and improves vascular lesions in retinas of diabetic rats. Mol Vis. 2011;17: 3166–3174. PMCID: PMC3235535.

17.

Li MC, Liu YG, Zhang D, Wang DL. Dahuang su dui da shu tangniaobing shiwangmo bingbian fazhan de yingxiang [effect of emodin on the progression of diabetic retinopathy in rats]. Heilongjiang Med Pharm. 2014;37(3):71–1. https://doi.org/10.3969/j.issn.1008-0104.2014.03.037.

18.

Van Bergen NJ, Wood JP, Chidlow G, Trounce IA, Casson RJ, Ju WK, et al. Recharacterization of the RGC-5 retinal ganglion cell line. Invest Ophthalmol Vis Sci. 2009;50(9):4267–72. https://doi.org/10.1167/iovs.09-3484.CrossRef

19.

Tasca CI, Dal-Cim T, Cimarosti H. In vitro oxygen-glucose deprivation to study ischemic cell death. Methods Mol Biol. 2015;1254:197–210. https://doi.org/10.1007/978-1-4939-2152-2_15.CrossRef

20.

Tsai TI, Bui BV, Vingrys AJ. Dimethyl sulphoxide dose–response on rat retinal function. Doc Ophthalmol. 2009;119(3):199–207. https://doi.org/10.1007/s10633-009-9191-8.CrossRefPubMed

21.

Wu C, Chen J, Chen C, Wang W, Wen L, Gao K, et al. Wnt/β-catenin coupled with HIF-1α/VEGF signaling pathways involved in galangin neurovascular unit protection from focal cerebral ischemia. Sci Rep. 2015;5:16151. https://doi.org/10.1038/srep16151.CrossRef

22.

Li Y, Xu QQ, Shan CS, Shi YH, Wang Y, Zheng GQ. Combined use of Emodin and Ginsenoside Rb1 exerts synergistic Neuroprotection in cerebral ischemia/reperfusion rats. Front Pharmacol. 2018;9:943. https://doi.org/10.3389/fphar.2018.00943.CrossRef

23.

Ren H, Zhu C, Li Z, Yang W, Song E. Emodin-loaded magnesium silicate hollow Nanocarriers for anti-angiogenesis treatment through inhibiting VEGF. Int J Mol Sci. 2014;15(9):16936–48. https://doi.org/10.3390/ijms150916936.CrossRef

24.

Kwak HJ, Park MJ, Park CM, Moon SI, Yoo DH, Lee HC, et al. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation. Int J Cancer. 2006;118(11):2711–20. https://doi.org/10.1002/ijc.21641.CrossRef

25.

Ma J, Lu H, Wang S, Chen B, Liu Z, Ke X, et al. The anthraquinone derivative Emodin inhibits angiogenesis and metastasis through downregulating Runx2 activity in breast cancer. Int J Oncol. 2015;46(4):1619–28. https://doi.org/10.3892/ijo.2015.2888.CrossRef

26.

Wu JH, Liu JH, Ko YC, Wang CT, Chung YC, Chu KC, et al. Haploinsufficiency of RCBTB1 is associated with coats’ disease and familial exudative vitreoretinopathy. Hum Mol Genet. 2016;25(8):1637–47 https://doi.org/10.1093/hmg/ddw041.CrossRef

Title: Emodin protected against retinal ischemia insulted neurons through the downregulation of protein overexpression of β-catenin and vascular endothelium factor
Authors: Howard Wen-Haur Chao
Yu-Kuang Chen
Jorn-Hon Liu
Hwai-Tzong Pan
Hsin-May Lin
Hsiao-Ming Chao
Publication date: 01-12-2020
Publisher: BioMed Central
Published in: BMC Complementary Medicine and Therapies / Issue 1/2020
Electronic ISSN: 2662-7671
DOI: https://doi.org/10.1186/s12906-020-03136-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Emodin protected against retinal ischemia insulted neurons through the downregulation of protein overexpression of β-catenin and vascular endothelium factor

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

Effects of Qilin pills on spermatogenesis, reproductive hormones, oxidative stress, and the TSSK2 gene in a rat model of oligoasthenospermia

Gas chromatography-mass spectrometry analysis, phytochemical screening and antiprotozoal effects of the methanolic Viola tricolor and acetonic Laurus nobilis extracts

Krill oil extract inhibits the migration of human colorectal cancer cells and down-regulates EGFR signalling and PD-L1 expression

Cytotoxycity and antiplasmodial activity of phenolic derivatives from Albizia zygia (DC.) J.F. Macbr. (Mimosaceae)

Phyllanthus amarus prevents LPS-mediated BV2 microglial activation via MyD88 and NF-κB signaling pathways

Phytochemical analysis and in vitro anti-proliferative activity of Viscum album ethanolic extracts